Literature DB >> 31969946

Transcatheter closure of perimembranous ventricular septal defects with Amplatzer® duct occluder I; The first case report in Japan.

Takanari Fujii1, Takashi Higaki2, Hideshi Tomita1, Kota Nagaoka1, Hideki Yamaguchi1, Takeshi Shimizu1, Nobuo Oyama1, Takeshi Sasaki1, Dai Asada1, Yoshihito Hata1, Suguru Tarui1, Yoshinori Miyahara1, Kozo Ishino1, Takashi Soga3, Masaaki Ota2.   

Abstract

We report the first case of transcatheter perimembranous ventricular septal defect (pmVSD) closure in Japan where none of existing devices for VSD closure has been approved. The pmVSD was successfully closed with first generation Amplatzer® duct occluder (ADO-I; St Jude Medical, St Paul, MN, USA). The procedure was performed under general anesthesia with transesophageal echocardiographic and fluoroscopic guidance. The left ventricular volume overload after the procedure was remarkably improved and no major complications occurred. ADO-I can be a safe and effective option for transcatheter pmVSD closure. The incidence of heart block may be less than reported with the original device. <Learning objective: Use of Amplatzer® duct occluder is effective in transcatheter perimembranous ventricular septal defect (pmVSD) closure in selected patients. It may be safer than original Amplatzer pmVSD occluder to avoid complete atrioventricular block.>.
© 2019 Published by Elsevier Ltd on behalf of Japanese College of Cardiology.

Entities:  

Keywords:  Amplatzer®; Congenital heart disease; Duct occluder; Interventional cardiology; Ventricular septal defect

Year:  2019        PMID: 31969946      PMCID: PMC6962719          DOI: 10.1016/j.jccase.2019.08.004

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  10 in total

Review 1.  Morphology of perimembranous ventricular septal defects: implications for transcatheter device closure.

Authors:  Siew Yen Ho; Karen P McCarthy; Micheal L Rigby
Journal:  J Interv Cardiol       Date:  2004-04       Impact factor: 2.279

2.  Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association.

Authors:  Timothy F Feltes; Emile Bacha; Robert H Beekman; John P Cheatham; Jeffrey A Feinstein; Antoinette S Gomes; Ziyad M Hijazi; Frank F Ing; Michael de Moor; W Robert Morrow; Charles E Mullins; Kathryn A Taubert; Evan M Zahn
Journal:  Circulation       Date:  2011-05-02       Impact factor: 29.690

3.  Transcatheter closure of perimembranous ventricular septal defect using Amplatzer ductal occluder.

Authors:  Sang Mi Lee; Jin Young Song; Jae Young Choi; Sang Yoon Lee; Jae Sook Paik; So Ick Chang; Woo Seop Shim; Seong Ho Kim
Journal:  Catheter Cardiovasc Interv       Date:  2013-08-20       Impact factor: 2.692

4.  Transcatheter closure of congenital perimembranous ventricular septal defect in children using symmetric occluders: an 8-year multiinstitutional experience.

Authors:  Lei Wang; Sancheng Cao; Jun Li; Lifang Yang; Yin Liu; Jun Ren; Qiaomei Ma; Haijian Xing; Dan Li; Danqiu Tian; Yi Wan; Shiqiang Yu; Tao Chen; Xiuling Yang; Jian Yang
Journal:  Ann Thorac Surg       Date:  2012-05-23       Impact factor: 4.330

5.  Recent experience with transcatheter closure of perimembranous ventricular septal defects using duct occluders.

Authors:  Murat M Yılmazer; Timur Meşe; Barış Güven; Rahmi Özdemir; Mustafa Demirol; Şenay Çoban
Journal:  Cardiol Young       Date:  2016-04-13       Impact factor: 1.093

6.  Complete atrioventricular block after percutaneous device closure of perimembranous ventricular septal defect: A single-center experience on 1046 cases.

Authors:  Yuan Bai; Xu-Dong Xu; Chang-Yong Li; Jia-Qi Zhu; Hong Wu; Shao-Ping Chen; Feng Chen; Xiao-Hua You; Xian-Xian Zhao; Yong-Wen Qin
Journal:  Heart Rhythm       Date:  2015-05-14       Impact factor: 6.343

7.  Closure of perimembranous ventricular septal defects with aneurysmal tissue using the Amplazter Duct Occluder I: lessons learned and medium term follow up.

Authors:  Howaida G El Said; Andras Bratincsak; Brent M Gordon; John W Moore
Journal:  Catheter Cardiovasc Interv       Date:  2012-08-20       Impact factor: 2.692

8.  Transcatheter coil occlusion of perimembranous ventricular septal defects.

Authors:  Shunji Nogi; Noriyuki Haneda; Hideshi Tomita; Kenji Yasuda
Journal:  Catheter Cardiovasc Interv       Date:  2008-11-01       Impact factor: 2.692

9.  Transcatheter closure of perimembranous ventricular septal defects: early and long-term results.

Authors:  Gianfranco Butera; Mario Carminati; Massimo Chessa; Luciane Piazza; Angelo Micheletti; Diana Gabriella Negura; Raul Abella; Alessandro Giamberti; Alessandro Frigiola
Journal:  J Am Coll Cardiol       Date:  2007-09-04       Impact factor: 24.094

10.  Current expectations for surgical repair of isolated ventricular septal defects.

Authors:  Brandi Braud Scully; David L S Morales; Farhan Zafar; E Dean McKenzie; Charles D Fraser; Jeffrey S Heinle
Journal:  Ann Thorac Surg       Date:  2010-02       Impact factor: 4.330

  10 in total
  1 in total

1.  Percutaneous closure of moderate to large perimembranous ventricular septal defect in small children using left ventricular mid-cavity approach.

Authors:  Sanjiban Ghosh; Aritra Mukherji; Amitabha Chattopadhyay
Journal:  Indian Heart J       Date:  2020-09-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.